Assessment of Panobacumab as Adjunctive Immunotherapy for the Treatment of Nosocomial Pseudomonas Aeruginosa Pneumonia
European Journal of Clinical Microbiology and Infectious Diseases - Germany
doi 10.1007/s10096-014-2156-1
Full Text
Open PDFAbstract
Available in full text
Date
May 24, 2014
Authors
Publisher
Springer Science and Business Media LLC